Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Inactivated EV71 Vaccine in Children
NCT02200237Phase 2Completed
- Sponsor
- Medigen Biotechnology
- Start
- Sep 2014
- Primary completion
- May 2017
- Modality
- Prophylactic Vaccines, DNA Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of EV71vac in enterovirus 71 infection, sponsored by Medigen Biotechnology. Started Sep 2014; status: completed.
02
Drugs
EV71vac
03
Conditions
enterovirus 71 infection
Beyond the preview
Go deeper on NCT02200237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02200237.